A brief overview of thoracic surgery in the United States
- PMID: 35242386
- PMCID: PMC8828520
- DOI: 10.21037/jtd-21-1504
A brief overview of thoracic surgery in the United States
Abstract
The 331 million people of the United States are served by a complex and expensive healthcare system that accounts for nearly 18% of the country's gross domestic product. Over 90% of patients are insured by private or government-funded plans, but despite high coverage and unusually high healthcare spending, vast disparities exist within the United States population based on demographics in terms of diagnosis, treatment, and outcomes of disease. Thoracic surgeons in the United States are trained to treat patients with diseases of the chest in the operative and perioperative settings, and can accomplish this training through multiple highly competitive pathways. Thoracic surgeons perform an average of 135 operations each per year which address diseases of the lungs, trachea, esophagus, chest wall, mediastinum, and diaphragm. Video assisted thoracoscopic surgeries are the most commonly performed procedures, which are primarily completed to treat lung cancer. Lung cancer is the deadliest and second most prevalent malignancy in the United States, with over 200,000 new cases expected this year. In addition to encouragement of smoking cessation and more attention to air pollutants, increased access to lung cancer screening has significantly expedited diagnosis and reduced mortality from lung cancer in the last several years. Thoracic surgeons in the United States are tasked with treating common yet highly morbid diseases of the chest in a patient population that is diverse in terms of race, socioeconomic status, and healthcare insurance coverage. As the population ages and a shortage of thoracic surgeons looms, the importance of early diagnosis, skillful surgical management, and attention to the disparities that exist in our system cannot be overstated.
Keywords: Thoracic surgery; United States; delivery of health care; healthcare disparities; lung neoplasms.
2022 Journal of Thoracic Disease. All rights reserved.
Conflict of interest statement
Conflicts of Interest: The authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-21-1504/coif). The series “Thoracic Surgery Worldwide” was commissioned by the editorial office without any funding or sponsorship. CB and LB report that this work was supported by the National Institute of Health (NIH). LB serves as VA Merit Award Principal Investigator, Director at Large, Board of Directors on Society of Thoracic Surgeons. She received consulting fees in Guidepoint Consulting. She serves on an advisory board for Johnson & Johnson for their engagement of Women in Surgery. There is no clinical interest. For Bristol Myers Squib she has participated in an expert panel to advise them regarding strategies to engage early stage lung cancer patients for immunotherapy. The authors have no other conflicts of interest to declare.
Figures
References
-
- Hartley C, Perry M, Rogers L. A Preliminary Analysis of U.S. and State-Level Results From the 2020 Census. US Census Bureau, 2021.
-
- Bureau UC. State Area Measurements and Internal Point Coordinates. The United States Census Bureau. Available online: https://www.census.gov/geographies/reference-files/2010/geo/state-area.html
-
- National Cancer Institute. SEER Cancer Stat Facts: Lung and Bronchus Cancer. SEER Cancer Stat Facts: Lung and Bronchus Cancer. 2021. Available online: https://seer.cancer.gov/statfacts/html/lungb.html
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials